Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BGM Group Ltd. (BGM) vs Citius Oncology, Inc. (CTOR)

BGM Group Ltd. and Citius Oncology, Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. and Citius Oncology, Inc. are of similar size ($104.6M and $97.6M). Citius Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 4.0×. BGM Group Ltd. has the higher net margin (1.96% vs 0.00%) and the higher return on invested capital (0.00% vs −67.2%). Across the 10 metrics below, BGM Group Ltd. leads on 9 and Citius Oncology, Inc. on 1.

Valuation

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
P/E 4.00 n/m 20.14
P/S n/m n/m 2.25
P/B n/m 2.81 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales (0.09) n/m 2.56
Earnings yield 25.00% (44.76%) (2.99%)
Free cash flow yield 0.00% (28.37%) 0.00%

Profitability

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Gross margin 6.54% — 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 1.96% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (126.58%) (0.40%)
Return on assets 0.00% (45.20%) (3.32%)
Return on invested capital 0.00% (67.15%) 0.00%

Growth

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) 10.00% (9.68%) —
Revenue growth, 5-year CAGR (5.39%) — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.50 0.05
Current ratio 1.25 0.73 2.31
Net debt to EBITDA 0.97 (0.40) 0.85

Dividend

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Market cap 104.61m 97.63m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack